Voriconazole + Voriconazole
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Aspergillosis, Aspergilloma
Conditions
Aspergillosis, Aspergilloma
Trial Timeline
Sep 1, 2011 → May 1, 2013
NCT ID
NCT01383993About Voriconazole + Voriconazole
Voriconazole + Voriconazole is a phase 2 stage product being developed by Pfizer for Aspergillosis, Aspergilloma. The current trial status is completed. This product is registered under clinical trial identifier NCT01383993. Target conditions include Aspergillosis, Aspergilloma.
What happened to similar drugs?
8 of 16 similar drugs in Aspergillosis, Aspergilloma were approved
Approved (8) Terminated (6) Active (6)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01383993 | Phase 2 | Completed |
| NCT00904995 | Phase 3 | Completed |
Competing Products
20 competing products in Aspergillosis, Aspergilloma